1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Laplante, S.R.
Aubry, N.
Bonneau, P.R.
Cameron, D.R.
Lagace, L.
Massariol, M.-J.
Montpetit, H.
Ploufe, C.
Kawai, S.H.
Fulton, B.D.
Chen, Z.
Ni, F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
N
1
N
C
N
2
N
O
N
3
N
C
N
4
N
H
N
5
N
H
N
6
N
H
N
7
N
H
N
8
N
N
N
9
S
C
N
10
N
C
N
11
N
O
N
12
N
C
N
13
N
O
N
14
N
H
N
15
N
H
N
16
N
H
N
17
N
H
N
18
N
H
N
19
N
H
N
20
N
H
N
21
N
N
N
22
S
C
N
23
N
C
N
24
N
O
N
25
N
C
N
26
N
C
N
27
N
C
N
28
N
C
N
29
N
N
N
30
N
O
N
31
N
H
N
32
N
H
N
33
N
H
N
34
N
H
N
35
N
H
N
36
N
H
N
37
N
H
N
38
N
H
N
39
N
H
N
40
N
H
N
41
N
H
N
42
N
H
N
43
N
H
N
44
N
H
N
45
N
H
N
46
N
N
N
47
S
C
N
48
N
C
N
49
N
O
N
50
N
C
N
51
N
O
N
52
N
O
N
53
N
H
N
54
N
H
N
55
N
H
N
56
N
H
N
57
N
H
N
58
N
H
N
59
N
H
N
60
N
N
N
61
S
C
N
62
N
C
N
63
N
O
N
64
N
C
Y
65
N
C
Y
66
N
C
Y
67
N
C
Y
68
N
C
Y
69
N
C
Y
70
N
C
N
71
N
O
N
72
N
O
N
73
N
H
N
74
N
H
N
75
N
H
N
76
N
H
N
77
N
H
N
78
N
H
N
79
N
H
N
80
N
H
N
81
N
H
N
82
N
H
N
83
N
H
N
84
N
N
N
85
S
C
N
86
N
C
N
87
N
O
N
88
N
C
N
89
N
C
N
90
N
C
N
91
N
O
N
92
N
H
N
93
N
H
N
94
N
H
N
95
N
H
N
96
N
H
N
97
N
H
N
98
N
H
N
99
N
H
N
100
N
H
N
101
N
H
N
102
N
H
N
1
N
doub
N
2
N
sing
N
3
N
sing
N
4
N
sing
N
5
N
sing
N
6
N
sing
N
7
N
sing
N
8
N
sing
N
9
N
sing
N
10
N
sing
N
11
N
sing
N
12
N
sing
N
13
N
doub
N
14
N
sing
N
15
N
sing
N
16
N
sing
N
17
N
sing
N
18
N
sing
N
19
N
sing
N
20
N
sing
N
21
N
sing
N
22
N
sing
N
23
N
sing
N
24
N
sing
N
25
N
doub
N
26
N
sing
N
27
N
sing
N
28
N
sing
N
29
N
sing
N
30
N
sing
N
31
N
sing
N
32
N
sing
N
33
N
sing
N
34
N
sing
N
35
N
sing
N
36
N
sing
N
37
N
sing
N
38
N
sing
N
39
N
sing
N
40
N
sing
N
41
N
sing
N
42
N
sing
N
43
N
sing
N
44
N
sing
N
45
N
sing
N
46
N
sing
N
47
N
sing
N
48
N
sing
N
49
N
doub
N
50
N
sing
N
51
N
sing
N
52
N
sing
N
53
N
sing
N
54
N
sing
N
55
N
sing
N
56
N
sing
N
57
N
sing
N
58
N
sing
N
59
N
sing
N
60
N
sing
N
61
N
sing
N
62
N
doub
N
63
N
sing
N
64
N
sing
N
65
N
sing
N
66
N
sing
Y
67
N
doub
Y
68
N
sing
Y
69
N
sing
N
70
N
sing
Y
71
N
doub
N
72
N
sing
Y
73
N
doub
N
74
N
sing
Y
75
N
sing
N
76
N
sing
N
77
N
sing
N
78
N
sing
N
79
N
sing
N
80
N
sing
N
81
N
sing
N
82
N
sing
N
83
N
sing
N
84
N
sing
N
85
N
sing
N
86
N
doub
N
87
N
sing
N
88
N
sing
N
89
N
sing
N
90
N
sing
N
91
N
sing
N
92
N
sing
N
93
N
sing
N
94
N
sing
N
95
N
sing
N
96
N
sing
N
97
N
sing
US
Biochemistry
BICHAW
0033
0006-2960
37
9793
9801
10.1021/bi980555v
9657693
Human cytomegalovirus protease complexes its substrate recognition sequences in an extended peptide conformation.
1998
10.2210/pdb1bfz/pdb
pdb_00001bfz
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
593.693
HCMV PROTEASE R-SITE N-TERMINAL CLEAVAGE PRODUCT
TERESYVKA N-TERMINAL RESIDUES OF R-SITE PEPTIDE
1
syn
polymer
no
yes
(ACE)SYVKA
XSYVKA
A
polypeptide(L)
n
n
n
n
n
n
chem_comp_atom
chem_comp_bond
database_2
pdbx_database_status
pdbx_nmr_software
struct_conn
struct_site
repository
Initial release
Version format compliance
Atomic model
Database references
Derived calculations
Non-polymer description
Structure summary
Version format compliance
Data collection
Database references
Derived calculations
Other
1
0
1999-05-25
1
1
2008-03-24
1
2
2011-07-13
1
3
2024-06-05
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_pdbx_nmr_software.name
_struct_conn.pdbx_leaving_atom_flag
_struct_conn.ptnr1_auth_comp_id
_struct_conn.ptnr1_auth_seq_id
_struct_conn.ptnr1_label_atom_id
_struct_conn.ptnr1_label_comp_id
_struct_conn.ptnr1_label_seq_id
_struct_conn.ptnr2_auth_comp_id
_struct_conn.ptnr2_auth_seq_id
_struct_conn.ptnr2_label_atom_id
_struct_conn.ptnr2_label_comp_id
_struct_conn.ptnr2_label_seq_id
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
Y
BNL
1998-05-25
REL
TRANSFERRED NUCLEAR OVERHAUSER EFFECT SPECTROSCOPY 50, 150, 250 MS MIXING TIMES USED TO GENERATE RESTRAINTS
POTENTIAL ENERGY, MINIMAL RESTRAINT VIOLATIONS
50
32
TRNOESY
NOESY
TOCSY
7.0
285
K
REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE. CFF95 FORCEFIELD USED.
RESTRAINED SIMULATED ANNEALING
4
0.5M NA2SO4, 50MM NACL, 1MM EDTA, 5MM DTT-D10 IN 10% D2O SPIKED WITH TSP-2,2,3,3-D4
MSI
refinement
Discover
95.5
structure solution
Discover
95.5
400
Bruker
AMX400
500
Bruker
AMX500
600
Bruker
DRX500
600
Bruker
DMX600
ACE
6
n
1
ACE
6
A
SER
5
n
2
SER
5
A
TYR
4
n
3
TYR
4
A
VAL
3
n
4
VAL
3
A
LYS
2
n
5
LYS
2
A
ALA
1
n
6
ALA
1
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
9.83
1.50
110.50
120.33
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
3
9.88
1.50
110.50
120.38
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
4
10.32
1.50
110.50
120.82
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
5
9.77
1.50
110.50
120.27
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
6
9.51
1.50
110.50
120.01
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
8
9.48
1.50
110.50
119.98
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
9
9.80
1.50
110.50
120.30
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
10
11.42
1.50
110.50
121.92
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
11
9.74
1.50
110.50
120.24
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
12
11.13
1.50
110.50
121.63
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
13
11.49
1.50
110.50
121.99
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
14
11.30
1.50
110.50
121.80
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
16
9.20
1.50
110.50
119.70
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
18
9.74
1.50
110.50
120.24
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
20
11.28
1.50
110.50
121.78
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
21
11.51
1.50
110.50
122.01
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
22
11.10
1.50
110.50
121.60
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
23
9.73
1.50
110.50
120.23
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
24
11.34
1.50
110.50
121.84
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
25
9.71
1.50
110.50
120.21
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
26
9.54
1.50
110.50
120.04
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
28
11.38
1.50
110.50
121.88
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
29
11.32
1.50
110.50
121.82
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
30
9.66
1.50
110.50
120.16
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
31
11.45
1.50
110.50
121.95
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
32
10.29
1.50
110.50
120.79
A
A
A
N
CA
CB
SER
SER
SER
5
5
5
N
1
A
A
C
OXT
ALA
ALA
1
1
0.126
0.019
1.229
1.355
N
2
A
A
C
OXT
ALA
ALA
1
1
0.127
0.019
1.229
1.356
N
3
A
A
C
OXT
ALA
ALA
1
1
0.126
0.019
1.229
1.355
N
4
A
A
C
OXT
ALA
ALA
1
1
0.127
0.019
1.229
1.356
N
5
A
A
C
OXT
ALA
ALA
1
1
0.126
0.019
1.229
1.355
N
6
A
A
C
OXT
ALA
ALA
1
1
0.126
0.019
1.229
1.355
N
7
A
A
C
OXT
ALA
ALA
1
1
0.131
0.019
1.229
1.360
N
8
A
A
C
OXT
ALA
ALA
1
1
0.131
0.019
1.229
1.360
N
9
A
A
C
OXT
ALA
ALA
1
1
0.131
0.019
1.229
1.360
N
10
A
A
C
OXT
ALA
ALA
1
1
0.126
0.019
1.229
1.355
N
11
A
A
C
OXT
ALA
ALA
1
1
0.127
0.019
1.229
1.356
N
12
A
A
C
OXT
ALA
ALA
1
1
0.126
0.019
1.229
1.355
N
13
A
A
C
OXT
ALA
ALA
1
1
0.131
0.019
1.229
1.360
N
14
A
A
C
OXT
ALA
ALA
1
1
0.126
0.019
1.229
1.355
N
15
A
A
C
OXT
ALA
ALA
1
1
0.130
0.019
1.229
1.359
N
16
A
A
C
OXT
ALA
ALA
1
1
0.131
0.019
1.229
1.360
N
17
A
A
C
OXT
ALA
ALA
1
1
0.132
0.019
1.229
1.361
N
18
A
A
C
OXT
ALA
ALA
1
1
0.126
0.019
1.229
1.355
N
19
A
A
C
OXT
ALA
ALA
1
1
0.131
0.019
1.229
1.360
N
20
A
A
C
OXT
ALA
ALA
1
1
0.132
0.019
1.229
1.361
N
21
A
A
C
OXT
ALA
ALA
1
1
0.126
0.019
1.229
1.355
N
22
A
A
C
OXT
ALA
ALA
1
1
0.131
0.019
1.229
1.360
N
23
A
A
C
OXT
ALA
ALA
1
1
0.135
0.019
1.229
1.364
N
24
A
A
C
OXT
ALA
ALA
1
1
0.129
0.019
1.229
1.358
N
25
A
A
C
OXT
ALA
ALA
1
1
0.126
0.019
1.229
1.355
N
26
A
A
C
OXT
ALA
ALA
1
1
0.126
0.019
1.229
1.355
N
27
A
A
C
OXT
ALA
ALA
1
1
0.131
0.019
1.229
1.360
N
28
A
A
C
OXT
ALA
ALA
1
1
0.125
0.019
1.229
1.354
N
29
A
A
C
OXT
ALA
ALA
1
1
0.131
0.019
1.229
1.360
N
30
A
A
C
OXT
ALA
ALA
1
1
0.130
0.019
1.229
1.359
N
31
A
A
C
OXT
ALA
ALA
1
1
0.126
0.019
1.229
1.355
N
32
A
A
C
OXT
ALA
ALA
1
1
0.133
0.019
1.229
1.362
N
6
A
LYS
2
-88.61
49.40
10
A
LYS
2
-92.17
54.96
15
A
TYR
4
75.20
177.66
BOUND CONFORMATION OF N-TERMINAL CLEAVAGE PRODUCT PEPTIDE MIMIC (P1-P9 OF RELEASE SITE) WHILE BOUND TO HCMV PROTEASE AS DETERMINED BY TRANSFERRED NOESY EXPERIMENTS (P1-P5 SHOWN ONLY), NMR, 32 STRUCTURES
1
Y
N
covale
1.376
both
A
SER
5
A
N
SER
2
1_555
A
ACE
6
A
C
ACE
1
1_555
PEPTIDE
SUBSTRIATE CLEAVAGE, BOUND CONFORMATION, EXTENDED CONFORMATION, substrate-based competitive inhibitor design
1BFZ
PDB
1
1BFZ
6
1
1BFZ
6
1
1BFZ
A
1
1
6
BINDING SITE FOR RESIDUE ACE A 6
A
ACE
6
Software
2
A
TYR
4
A
TYR
3
2
1_555
A
SER
5
A
SER
2
2
1_555
1
P 1